Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer.
Tomishima K, Ishii S, Fujisawa T, Ikemura M, Ota H, Kabemura D, Ushio M, Fukuma T, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Saito H, Nagahara A, Isayama H. Tomishima K, et al. Among authors: ota h. Cancers (Basel). 2021 Aug 22;13(16):4224. doi: 10.3390/cancers13164224. Cancers (Basel). 2021. PMID: 34439377 Free PMC article.
Current Situation and Problems in Diagnosis of Early Chronic Pancreatitis.
Ito K, Takasaki Y, Fujisawa T, Ishii S, Tomishima K, Takahashi S, Ikoma I, Jimbo Y, Ota H, Kabemura D, Ikemura M, Ushio M, Fukuma T, Suzuki A, Isayama H. Ito K, et al. Among authors: ota h. Pancreas. 2023 May 1;52(5):e275-e281. doi: 10.1097/MPA.0000000000002252. Epub 2023 Oct 2. Pancreas. 2023. PMID: 37782891
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease.
Imaizumi T, Yokota T, Funakoshi K, Yasuda K, Hattori A, Morohashi A, Kusakabe T, Shojima M, Nagamine S, Nakano T, Huang Y, Morinaga H, Ohta M, Nagashima S, Inoue R, Nakamura N, Ota H, Maruyama T, Gobara H, Endoh A, Ando M, Shiratori Y, Maruyama S. Imaizumi T, et al. Among authors: ota h. Clin Exp Nephrol. 2025 Jan 6. doi: 10.1007/s10157-024-02614-3. Online ahead of print. Clin Exp Nephrol. 2025. PMID: 39762534
Correction: Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH.
Tomomasa D, Tanita K, Hiruma Y, Hoshino A, Kudo K, Azumi S, Shiota M, Yamaoka M, Eguchi K, Ishimura M, Tanaka Y, Iwatsuki K, Okuno K, Hama A, Sakamoto KI, Taga T, Goto K, Ota H, Ichiki A, Kanda K, Miyamura T, Endo S, Ohnishi H, Sasahara Y, Arai A, Fournier B, Imadome KI, Morio T, Latour S, Kanegane H. Tomomasa D, et al. Among authors: ota h. Int J Hematol. 2024 Dec 16. doi: 10.1007/s12185-024-03886-x. Online ahead of print. Int J Hematol. 2024. PMID: 39680352 No abstract available.
Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Exercise-Induced Pulmonary Hypertension.
Satoh T, Yaoita N, Higuchi S, Nochioka K, Yamamoto S, Sato H, Tatebe S, Yamada K, Yamada Y, Komaru K, Chiba N, Sarashina Y, Mori R, Nakada M, Hayashi H, Suzuki H, Takahama H, Ota H, Yasuda S. Satoh T, et al. Among authors: ota h. Pulm Circ. 2024 Dec 15;14(4):e70026. doi: 10.1002/pul2.70026. eCollection 2024 Oct. Pulm Circ. 2024. PMID: 39678732 Free PMC article.
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.
Shiozawa M, Sunakawa Y, Watanabe T, Ota H, Yasui H, Yabuno T, Tei M, Kochi M, Manaka D, Ohori H, Yamaguchi T, Sagawa T, Kotaka M, Kubota Y, Sekikawa T, Nakamura M, Takeuchi M, Ichikawa W, Fujii M, Tsuji A. Shiozawa M, et al. Among authors: ota h. Nat Commun. 2024 Nov 25;15(1):10217. doi: 10.1038/s41467-024-54460-2. Nat Commun. 2024. PMID: 39587053 Free PMC article. Clinical Trial.
1,476 results